DXR Stock Summary and Trading Ideas (Daxor - Closed End | NASDAQ:DXR)

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

What symbol and exchange does Daxor - Closed End shares trade?

Daxor - Closed End trades on the NASDAQ stock market under the symbol DXR.

What is Daxor - Closed End stock price doing today?

As of March 5, 2026, DXR stock price declined to $11.45 with 1,136 million shares trading.

How much is Daxor - Closed End worth?

DXR has a market cap of $66.72 million. This is considered a Micro Cap stock.

What is the highest and lowest price Daxor - Closed End traded in the last 3 year period?

In the last 3 years, DXR traded as high as $14.76 and as low as $6.55.

What are the top ETFs holding Daxor - Closed End?

The top ETF exchange traded funds that DXR belongs to (by Net Assets): VTI.

Is Daxor - Closed End (DXR) a good investment?

DXR has outperformed the market in the last year with a return of +51.9%, while the SPY ETF gained +19.4%. However, in the most recent history, DXR shares have underperformed the stock market with its stock returning -10.9% in the last 3 month period and -6.1% for the last 2 week period, while SPY has returned -0.2% and -0.7%, respectively.

What are the support and resistance levels for Daxor - Closed End (DXR)?

DXR support price is $11.16 and resistance is $12.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DXR shares will trade within this expected range on the day.